Advertisement

Cancer Chemotherapy and Pharmacology

, Volume 17, Issue 2, pp 114–120 | Cite as

Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide

  • A. C. M. Kroes
  • J. Lindemans
  • M. Schoester
  • J. Abels
Original Articles Methotrexate, Nitrous Oxide, Vitamin B12

Summary

Exposure to nitrous oxide interferes selectively with the coenzyme function of vitamin B12 and causes inactivation of methionine synthetase, with subsequent impairment of folate metabolism and reduction of cellular proliferation. In a rat leukemia model (BNML) we investigated the combined administration of nitrous oxide, inactivating vitamin B12, and methotrexate (MTX), a folate antagonist inhibiting the enzyme dihydrofolate reductase. Through different mechanisms, both agents decrease the availability of tetrahydrofolate, and subsequently of other reduced folates, with increased impairment of folate-dependent synthesis of thymidylate. Effects on leukemic growth and on hematological values in rats demonstrated enhancement of the therapeutic effect of MTX by exposure to nitrous oxide. With several treatment schedules, the results of combined treatment were seen to be better than additive when compared with the effects of single agents. In particular, pretreatment of leukemic rats with nitrous oxide for 3 days before administration of MTX appeared effective. With higher doses of MTX, concomitant exposure to nitrous oxide even resulted in toxic effects. These findings were in accordance with the results of some metabolic studies performed in leukemic rats. De novo synthesis of thymidylate in leukemic cells, when studied by means of the deoxyuridine suppression test, showed the most severe disturbance with combined treatment consisting in MTX (0.5 mg/kg) and nitrous oxide pretreatment for 3 days. Intracellular levels of folate and dTTP were lowest with 2 and 3 days' pretreatment before MTX, respectively. It is concluded that this interaction of nitrous oxide and MTX can result in enhanced metabolic and therapeutic effects of low doses of MTX. Inactivation of vitamin B12 appears to be a potentially useful addition in cancer chemotherapy.

Keywords

Folate Nitrous Oxide Cobalamin Deoxyuridine dTTP 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations used in this paper

MTX

methotrexate

THF

tetrahydrofolate

DHF

dihydrofolate

dTTP

deoxythymidine triphosphate

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amess JAL, Burman JF, Ress GM, Nancekievill DG, Mollin DL (1978) Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet 2:339Google Scholar
  2. 2.
    Banks RGS, Henderson RJ, Pratt JM (1968) Reactions of gases in solution: III. Some reactions of nitrous oxide with transition-metal complexes. J Chem Soc [A] 12:2886Google Scholar
  3. 3.
    Barford PA, Blair JA, Malghani MAK (1980) The effect of methotrexate on folate metabolism in the rat. Br J Cancer 41:816Google Scholar
  4. 4.
    Black KA, Tephly TR (1983) Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats. Mol Pharmacol 23:724Google Scholar
  5. 5.
    Bruckner HW, Schreiber C, Waxman S (1975) Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis. Cancer Res 35:801Google Scholar
  6. 6.
    Chanarin I (1982) The effects of nitrous oxide on cobalamins, folates, and on related events. CRC Crit Rev Toxicol 10:179Google Scholar
  7. 7.
    Deacon R, Lumb M, Perry J, Chanarin I, Minty B, Halsey MJ, Nunn JF (1978) Selective inactivation of vitamin B12 in rats by nitrous oxide. Lancet 2:1023Google Scholar
  8. 8.
    Deacon R, Lumb M, Perry J, Chanarin I, Minty B, Halsey M, Nunn J (1980) Inactivation of methionine synthetase by nitrous oxide. Eur J Biochem 104:419Google Scholar
  9. 9.
    Deacon R, Perry J, Lumb M, Chanarin I (1981) The effect of nitrous oxide-induced inactivation of vitamin B12 on thymidylate synthetase activity of rat bone marrow cells. Biochem Biophys Res Commun 102:215Google Scholar
  10. 10.
    Dudman NPB, Slowiaczek P, Tattersall MHN (1982) Methotrexate rescue by 5-methyltetrahydrofolate or 5-formyltetrahydrofolate in lymphoblast cell lines. Cancer Res 42:502Google Scholar
  11. 11.
    Dunn RT, Foster LB (1973) Radioassay of serum folate. Clin Chem 19:1101Google Scholar
  12. 12.
    Hagenbeek A, Van Bekkum DW (eds) (1977) Proceedings of a workshop on comparative evaluation of the L5222 and the BNML rat leukaemia models and their relevance for human acute leukaemia. Leukemia Res 1:75Google Scholar
  13. 13.
    Hunting D, Henderson JF (1981) Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation. Can J Biochem 59:723Google Scholar
  14. 14.
    Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA (1983) The pharmacology and clinical use of methotrexate. N Engl J Med 309:1094Google Scholar
  15. 15.
    Jolivet J, Schilsky RL, Bailey BD, Drake JC, Chabner BA (1982) Synthesis, retention and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J Clin Invest 70:351Google Scholar
  16. 16.
    Kamen BA, Nylen PA, Camitta BM, Bertino JR (1981) Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug. Br J Haematol 49:355Google Scholar
  17. 17.
    Kano Y, Sakamoto S, Sakuraya K, Kubota T, Hida K, Suda K, Takaku F (1981) Effect of nitrous oxide on human bone marrow cells and its synergistic effect with methionine and methotrexate on functional folate deficiency. Cancer Res 41:4698Google Scholar
  18. 18.
    Kano Y, Sakamoto S, Sakuraya K, Kubota T, Kasahara T, Hida K, Suda K, Takaku F (1983) Effects of nitrous oxide on human cell lines. Cancer Res 43:1493Google Scholar
  19. 19.
    Kroes ACM, Lindemans J, Abels J (1984) Synergistic growth inhibiting effect of nitrous oxide and cycloleucine in experimental rat leukaemia. Br J Cancer 50:793Google Scholar
  20. 20.
    Kroes ACM, Lindemans J, Hagenbeek A, Abels J (1984) Nitrous oxide reduces growth of experimental rat leukemia. Leukemia Res 8:441Google Scholar
  21. 21.
    Lassen HCA, Henriksen E, Neukirch F, Kristensen HS (1956) Treatment of tetanus. Severe bone marrow depression after prolonged nitrous-oxide anaesthesia. Lancet 1:527Google Scholar
  22. 22.
    Lau KS, Gottlieb C, Wasserman LR, Herbert V (1965) Measurement of serum vitamin B12 level using radioisotope dilution and coated charcoal. Blood 26:202Google Scholar
  23. 23.
    Lavoie A, Tripp E, Hoffbrand AV (1974) The effect of vitamin B12 deficiency on methylfolate metabolism and pteroyl-polyglutamate synthesis in human cells. Clin Sci Mol Med 47:617Google Scholar
  24. 24.
    Ludwig Breast Cancer Study Group (1983) Toxic effects of early adjuvant chemotherapy for breast cancer. Lancet 2:542Google Scholar
  25. 25.
    Lumb M, Perry J, Deacon R, Chanarin I (1981) Changes in tissue tolates accompanying nitrous oxide-induced inactivation of vitamin B12 in the rat. Am J Clin Nutr 34:2412Google Scholar
  26. 26.
    Mandella R, DePaola DP (1984) Measurement of tissue folates: a comparison of radioassay and microbiological methods. Nutr Res 4:521Google Scholar
  27. 27.
    McGing P, Reed B, Weir DG, Scott JM (1978) The effect of vitamin B12 inhibition in vivo: impaired folate polyglutamate biosynthesis indicating that 5-methyltetrahydropteroylglutamate is not its usual substrate. Biochem Biophys Res Commun 82:540Google Scholar
  28. 28.
    McKenna B, Weir DG, Scott JM (1980) The induction of functional vitamin B12-deficiency in rats by exposure to nitrous oxide. Biochim Biophys Acta 628:314Google Scholar
  29. 29.
    McMartin KE, Virayotha V, Tephly TR (1981) High-pressure liquid chromatography separation and determination of rat liver folates. Arch Biochem Biophys 209:127Google Scholar
  30. 30.
    Metz J, Kelly A, Sweet VC, Waxman S, Herbert V (1968) Deranged DNA synthesis by bone marrow from vitamin B12-deficient humans. Br J Haematol 14:575Google Scholar
  31. 31.
    Moran RG, Colman PD (1984) Mammalian folyl polyglutamate synthetase: partial purification and properties of the mouse liver enyzme. Biochemistry 23:4580Google Scholar
  32. 32.
    Moran RG, Mulkins M, Heidelberger C (1979) Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. Proc Natl Acad Sci USA 76:5924Google Scholar
  33. 33.
    Muir M, Chanarin I (1984) Conversion of endogenous cobalamins into microbiologically-inactive cobalamin analogues in rats by exposure to nitrous oxide. Br J Haematol 58:517Google Scholar
  34. 34.
    Perry J, Chanarin I, Deacon R, Lumb M (1983) Chronic cobalamin inactivation impairs folate polyglutamate synthesis in the rat. J Clin Invest 71:1183Google Scholar
  35. 35.
    Perry J, Chanarin I, Deacon R, Lumb M (1985) Folate polyglutamate synthetase activity in the cobalamin-inactivated rat. Biochem J 227:73Google Scholar
  36. 36.
    Rachmilewitz D, Rachmilewitz EA, Poliack A, Hershko C (1972) Acute promyelocytic leukaemia: a report of five cases with a comment on the diagnostic significance of serum vitamin B12 determination. Br J Haematol 22:87Google Scholar
  37. 37.
    Rupreht J, Dzoljic MR (1982) Elimination of irritating compounds during chronic exposure to gases. J Pharmacol Methods 8:109Google Scholar
  38. 38.
    Skacel PO, Hewlett AM, Lewis JD, Lumb M, Nunn JF, Chanarin I (1983) Studies on the haemopoietic toxicity of nitrous oxide in man. Br J Haematol 53:189Google Scholar
  39. 39.
    Solter AW, Handschumacher RE (1969) A rapid quantitative determination of deoxyribonucleoside triphosphates based on the enzymatic synthesis of DNA. Biochim Biophys Acta 174:585Google Scholar
  40. 40.
    Van Bekkum DW, Hagenbeek A (1977) Relevance of the BN leukemia as a model for human acute myeloid leukemia. Blood Cells 3:565Google Scholar
  41. 41.
    Washtien WL (1982) Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells. Mol Pharmacol 21:723Google Scholar
  42. 42.
    Wickramasinghe SN (1981) The deoxyuridine suppression test: a review of its clinical and research applications. Clin Lab Haematol 3:1Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • A. C. M. Kroes
    • 1
  • J. Lindemans
    • 1
  • M. Schoester
    • 1
  • J. Abels
    • 1
  1. 1.Institute of HematologyErasmus UniversityRotterdamThe Netherlands

Personalised recommendations